Personalis at Precision: Colorectal Cancer Summit: July 14-15, 2020
Presentation
Kedar Hastak, PhD
Field Application Scientist
Tuesday, July 14 | 12:00 PM Pacific
Comprehensive solid tumor profiling enables composite biomarker discovery for immunotherapy response
- ImmunoID NeXT combines highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics to provide a broad view of the tumor and the immune-related components of the tumor microenvironment from a single sample preparation
- We will feature a case study demonstrating the ability of this unique, innovative immunogenomics profiling platform to uncover tumor escape mechanisms and to identify composite biomarkers of potentially greater predictive capacity
